REMASTER Trademark

Trademark Overview


On Monday, March 1, 2021, a trademark application was filed for REMASTER with the United States Patent and Trademark Office. The USPTO has given the REMASTER trademark a serial number of 90552860. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, July 2, 2024. This trademark is owned by Remix Therapeutics Inc.. The REMASTER trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and therapeutic pharmaceutical preparations for the treatment of cancer, immune system related diseases and disorders, cardiovascular diseases and disorders, genetic diseases and disorders, rare and orphan diseases, and neurological diseases and disorders

Pharmaceutical, medical, scientific, and biopharmaceutical research and development; Scientific research, pharmaceutical research, medical research; Technical and scientific research consultation in the fields of biotechnology and development of pharmaceuticals; Product development for others in the fields of biotechnology and development of pharmaceuticals
remaster

General Information


Serial Number90552860
Word MarkREMASTER
Filing DateMonday, March 1, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, July 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements


Goods and ServicesPharmaceutical and therapeutic pharmaceutical preparations for the treatment of cancer, immune system related diseases and disorders, cardiovascular diseases and disorders, genetic diseases and disorders, rare and orphan diseases, and neurological diseases and disorders
Goods and ServicesPharmaceutical, medical, scientific, and biopharmaceutical research and development; Scientific research, pharmaceutical research, medical research; Technical and scientific research consultation in the fields of biotechnology and development of pharmaceuticals; Product development for others in the fields of biotechnology and development of pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, May 30, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 23, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRemix Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameRemix Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Sunday, May 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 22, 2021ASSIGNED TO EXAMINER
Thursday, September 23, 2021EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, September 23, 2021COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Thursday, September 23, 2021EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, September 23, 2021NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, September 24, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 29, 2021ASSIGNED TO LIE
Thursday, September 30, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 4, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 10, 2022SOU TEAS EXTENSION RECEIVED
Monday, January 10, 2022SOU EXTENSION 1 FILED
Monday, January 10, 2022SOU EXTENSION 1 GRANTED
Wednesday, January 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 28, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 28, 2022SOU EXTENSION 2 FILED
Wednesday, December 28, 2022SOU EXTENSION 2 GRANTED
Friday, December 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 28, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 28, 2023SOU EXTENSION 3 GRANTED
Wednesday, June 28, 2023SOU EXTENSION 3 FILED
Friday, June 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 4, 2024SOU EXTENSION 4 FILED
Thursday, January 4, 2024SOU EXTENSION 4 GRANTED
Tuesday, July 2, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 2, 2024SOU EXTENSION 5 FILED
Tuesday, July 2, 2024SOU EXTENSION 5 GRANTED
Saturday, January 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED